Cargando…
Higher thymocyte selection-associated high mobility group box (TOX) expression predicts poor prognosis in patients with ovarian cancer
BACKGROUND: Ovarian cancer is one of the most lethal gynecologic malignancies with a dismal prognosis that poses a serious threat to human health, highlighting the need for more knowledge about what is required for identifying some biomarkers for early diagnosis, prediction of prognosis and disease...
Autores principales: | Li, Sai, Yang, Sifu, Hong, Yupeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701062/ https://www.ncbi.nlm.nih.gov/pubmed/36434543 http://dx.doi.org/10.1186/s12885-022-10336-6 |
Ejemplares similares
-
Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis
por: Huang, Yuanshen, et al.
Publicado: (2014) -
Computer-Aided Discovery of Small Molecule Inhibitors of Thymocyte Selection-Associated High Mobility Group Box Protein (TOX) as Potential Therapeutics for Cutaneous T-Cell Lymphomas
por: Agrawal, Vibudh, et al.
Publicado: (2019) -
Differential Epigenetic Regulation of TOX Subfamily High Mobility Group Box Genes in Lung and Breast Cancers
por: Tessema, Mathewos, et al.
Publicado: (2012) -
High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations
por: Maestre, Lorena, et al.
Publicado: (2020) -
Beyond the Bench: Tox-in-a-Box
por: Freeman, Kris
Publicado: (2005)